Yoshino S, Quattrocchi E, Weiner H L
Brigham and Women's Hospital, Boston, MA 02115, USA.
Arthritis Rheum. 1995 Aug;38(8):1092-6. doi: 10.1002/art.1780380811.
To assess the effect of orally administered type II collagen (CII) in antigen-induced arthritis (AIA).
Arthritis was induced in Lewis rats by immunization with methylated bovine serum albumin (mBSA) in Freund's complete adjuvant, followed by an intraarticular injection of mBSA 2 weeks later. Different doses of CII, mBSA, and an unrelated control protein, keyhole limpet hemocyanin (KLH), were orally administered 5 times over several days prior to the induction of arthritis. Ankle joint swelling and delayed-type hypersensitivity (DTH) responses were measured.
Joint swelling was significantly reduced at a dose of 3 micrograms and 30 micrograms of CII, but not at 300 micrograms. The most prominent suppression of AIA was observed when rats were fed 10 mg of mBSA, whereas oral KLH had no effect. DTH responses were significantly reduced in the mBSA-fed rats, but not in rats that were fed CII or KLH.
Oral CII can suppress arthritis in an animal model in which immunity to collagen does not play a role. The effect is dose dependent and occurs at lower doses of CII. These results demonstrate the biologic relevance of bystander suppression associated with oral tolerance, and the potential use of this approach to treat human inflammatory joint disease.
评估口服II型胶原蛋白(CII)在抗原诱导性关节炎(AIA)中的作用。
通过在弗氏完全佐剂中用甲基化牛血清白蛋白(mBSA)免疫Lewis大鼠诱导关节炎,2周后关节腔内注射mBSA。在诱导关节炎前的几天内,分5次口服不同剂量的CII、mBSA和一种无关的对照蛋白——钥孔戚血蓝蛋白(KLH)。测量踝关节肿胀和迟发型超敏反应(DTH)。
3微克和30微克剂量的CII可显著减轻关节肿胀,但300微克剂量则无此效果。当给大鼠喂食10毫克mBSA时,观察到对AIA的最显著抑制,而口服KLH则无作用。喂食mBSA的大鼠DTH反应显著降低,但喂食CII或KLH的大鼠则未降低。
口服CII可在一种胶原蛋白免疫不起作用的动物模型中抑制关节炎。该作用呈剂量依赖性,且在较低剂量的CII时即出现。这些结果证明了与口服耐受相关的旁观者抑制的生物学相关性,以及这种方法治疗人类炎性关节疾病的潜在用途。